Oncovir, Inc.
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Nasal Poly-ICLC (Hiltonol®) in Healthy COVID-19 Vaccinated Adults (NCT04672291) | Oncovir, Inc. | 2021-07-21 |
| Poly-ICLC (Hiltonol®) Vaccine In Malignant Pleural Mesothelioma (NCT04525859) | Oncovir, Inc. | 2020-08-19 |
| Poly-ICLC (Hiltonol) and Anti-PD1 or Anti-PD-L1 (NCT03721679) | Oncovir, Inc. | 2018-09-25 |
Track Oncovir, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.